S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Avita Medical, Inc. Common Stock

RCEL XNAS
$4.11 -0.07 (-1.67%) ▼ 15-min delayed
Open
$4.22
High
$4.22
Low
$4.01
Volume
214.9K
Market Cap
$126.49M

About Avita Medical, Inc. Common Stock

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 226 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $71.61M $-48,587,000 $-1.74
FY 2025 $71.61M $-48,587,000 $-1.74
Q3 2025 $17.06M $-13,187,000 $-0.46
Q2 2025 $18.42M $-9,920,000 $-0.38

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026
Calendar →

Related Market News

No specific coverage for RCEL yet. Check out our latest market news or earnings calendar.

Get RCEL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Avita Medical, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.